MedTrace Logo

The Effect of Toremifene Treatment to the Magnetic Resonance Imaging (MRI) Findings in Premenstrual Mastalgia

NCT00534846 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2009-05-13

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of toremifene treatment to the MRI findings of the breast in women suffering from premenstrual mastalgia.

Conditions

  • Breast Pain

Interventions

DRUG

toremifene

The medication is given in tablet form, and the participants are instructed to take one tablet daily from cycle day 15 until the next menstruation. The active (toremifene 20 mg) and control (placebo) tablets were identical in appearance.

DRUG

placebo

tablet equal to toremifene, one tablet daily from cycle day 15 to menstruation during three cycles

Sponsors & Collaborators

  • Tampere University

    collaborator OTHER

  • Satakunta Central Hospital

    lead OTHER

Principal Investigators

  • SINIKKA OKSA, MD · Satakunta Central Hospital

  • JOHANNA MÄENPÄÄ · Tampere University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2008-05-31
Completion
2009-02-28

Countries

  • Finland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00534846 on ClinicalTrials.gov